Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605356 | Methods of treating pancreatic cancer | 🖼🧊📄§ | 2026-04-21 | 2043-10-26 | 0 | 31 |
| 12606572 | Substituted heterocycles and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2045-10-07 | 0 | 31 |
| 12605431 | Composition for treating or preventing myopathy, obesity or diabetes | 🖼🧊📄§ | 2026-04-21 | 2041-12-14 | 0 | 31 |
| 12606598 | Chimeric klebicins | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12605363 | Oxymetazoline compositions | 🖼🧊📄§ | 2026-04-21 | 2042-12-23 | 0 | 31 |
| 12606637 | Heparanase-neutralizing A54 monoclonal antibody | 🖼🧊📄§ | 2026-04-21 | 2041-07-06 | 0 | 31 |
| 12605409 | Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders | 🖼🧊📄§ | 2026-04-21 | 2043-04-14 | 0 | 31 |
| 12605460 | Stem cell-nano drug delivery system complex, use thereof and method for preparing the same | 🖼🧊📄§ | 2026-04-21 | 2044-06-21 | 0 | 31 |
| 12606612 | Multivalent DNA antibody constructs and use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-07-31 | 0 | 31 |
| 12605428 | Kinase NEK10 and its use in treating and diagnosing bronchiectasis and other respiratory disorders | 🖼🧊📄§ | 2026-04-21 | 2041-01-19 | 0 | 31 |
| 12605390 | Treatment of cancer and inhibition of metastasis | 🖼🧊📄§ | 2026-04-21 | 2041-10-27 | 0 | 31 |
| 12606635 | Glypican-2-binding moieties, chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-03-12 | 0 | 31 |
| 12605380 | Methods of improving lung function | 🖼🧊📄§ | 2026-04-21 | 2045-09-12 | 0 | 31 |
| 12606613 | Humanized anti-C5a antibodies | 🖼🧊📄§ | 2026-04-21 | 2041-05-06 | 0 | 31 |
| 12605373 | Methods and compositions of inhibiting DCN1-UBC12 interaction | 🖼🧊📄§ | 2026-04-21 | 2044-03-05 | 0 | 31 |
| 12605401 | Polymers, compositions and methods for treating hyperuricemia | 🖼🧊📄§ | 2026-04-21 | 2042-05-18 | 0 | 31 |
| 12606616 | PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer | 🖼🧊📄§ | 2026-04-21 | 2045-12-08 | 0 | 31 |
| 12606624 | Antibody that specifically binds to human CTLA4 and medicaments and kits comprising the same | 🖼🧊📄§ | 2026-04-21 | 2043-08-27 | 0 | 31 |
| 12606619 | Human monoclonal antibodies against TIGIT for immune related diseases | 🖼🧊📄§ | 2026-04-21 | 2041-06-23 | 0 | 31 |
| 12605425 | TNF muteins and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-26 | 0 | 31 |
| 12605444 | Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same | 🖼🧊📄§ | 2026-04-21 | 2041-01-08 | 0 | 31 |
| 12605426 | Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof | 🖼🧊📄§ | 2026-04-21 | 2041-02-15 | 0 | 31 |
| 12605413 | Engineered probiotics for treatment and immunity against viruses | 🖼🧊📄§ | 2026-04-21 | 2041-04-19 | 0 | 31 |
| 12606824 | Micro-RNA profiling, compositions, and methods of treating diseases | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12606606 | Nucleic acid construct that encodes chimeric rhodopsin | 🖼🧊📄§ | 2026-04-21 | 2040-09-11 | 0 | 31 |
| 12606803 | Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12606796 | Delivery of oncolytic viruses using dendritic cells | 🖼🧊📄§ | 2026-04-21 | 2040-05-07 | 0 | 31 |
| 12606607 | T cell receptors | 🖼🧊📄§ | 2026-04-21 | 2042-10-13 | 0 | 31 |
| 12606825 | Compositions and methods for modulating RPGR expression | 🖼🧊📄§ | 2026-04-21 | 2041-03-04 | 0 | 31 |
| 12606634 | Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 | 🖼🧊📄§ | 2026-04-21 | 2044-04-08 | 0 | 31 |
| 12605367 | Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies | 🖼🧊📄§ | 2026-04-21 | 2040-09-15 | 0 | 31 |
| 12605368 | Suppression of neuroinflammation and composition and method therefor | 🖼🧊📄§ | 2026-04-21 | 2041-03-31 | 0 | 31 |
| 12605438 | SARS-CoV-2 vaccines and antibodies | 🖼🧊📄§ | 2026-04-21 | 2043-03-02 | 0 | 31 |
| 12605455 | CAR peptide for improved coronavirus survival | 🖼🧊📄§ | 2026-04-21 | 2041-03-19 | 0 | 31 |
| 12605472 | Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-09-17 | 0 | 31 |
| 12605430 | High-activity blood coagulation factor XI mutant Ala570Thr | 🖼🧊📄§ | 2026-04-21 | 2041-04-13 | 0 | 31 |
| 12606805 | Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents | 🖼🧊📄§ | 2026-04-21 | 2043-08-29 | 0 | 31 |
| 12605396 | Methods of treating mastitis with an orthosomycin antimicrobial compound | 🖼🧊📄§ | 2026-04-21 | 2041-12-23 | 0 | 31 |
| 12605359 | Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and pharmaceutical use therefor | 🖼🧊📄§ | 2026-04-21 | 2041-01-27 | 0 | 31 |
| 12605354 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | 🖼🧊📄§ | 2026-04-21 | 2041-02-19 | 0 | 31 |
| 12605417 | Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders | 🖼🧊📄§ | 2026-04-21 | 2044-09-27 | 0 | 31 |
| 12605442 | Production of vaccines comprising inactivated SARS-CoV-2 viral particles | 🖼🧊📄§ | 2026-04-21 | 2041-03-05 | 0 | 31 |
| 12606555 | Chemical compounds | 🖼🧊📄§ | 2026-04-21 | 2042-04-07 | 0 | 31 |
| 12606523 | Deuterated organic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605351 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | 🖼🧊📄§ | 2026-04-21 | 2040-02-06 | 0 | 31 |
| 12605463 | Tolerogenic artificial antigen-presenting cells | 🖼🧊📄§ | 2026-04-21 | 2040-06-12 | 0 | 31 |
| 12605423 | Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2 | 🖼🧊📄§ | 2026-04-21 | 2041-09-08 | 0 | 31 |
| 12605419 | Flavonoid extract of Cyclocarya paliurus leaves and antibacterial drugs and/or antibacterial agents containing thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-20 | 0 | 31 |
| 12605458 | Antibody-drug conjugate having acidic self-stabilization junction | 🖼🧊📄§ | 2026-04-21 | 2038-06-15 | 0 | 31 |
| 12606571 | Macrocyclic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-04-09 | 0 | 31 |